rss
05-30-2015, 03:01 PM
Choroidal Neovascularization (CNV) Market 2015 will grow at a CAGR of 6.77% during 2013-2018
Choroidal Neovascularization (CNV) is defined as a process in which new blood vessels grow in the choroid through the bruch membrane, which is the innermost layer of the choroid, and attack the sub-retinal space. Even though most causes are idiopathic, the k**wn causes are related to degeneration, infections, choroidal tumors and/or trauma. As there is currently ** medical treatment for this disease, this ab**rmal growth can easily lead to impairment of sight or complete loss of vision.
Global CNV market will grow at a CAGR of 6.77 percent over the period 2013-2018. (http://www.marketresearchstore.com/report/global-choroidal-neovascularization-market-2014-2018-10760)
Covered in this Report
This report covers the present scenario and the growth prospects of the Global CNV market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of CNV
The report, the Global CNV Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global CNV market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
– Americas
– EMEA
– APAC
Key Vendors
– Bayer AG
– F. Hoffmann-La Roche Ltd.
– **vartis AG
– Regeneron Pharmaceuticals Inc.
Request For*Report Sample @ http://www.marketresearchstore.com/report/global-choroidal-neovascularization-market-2014-2018-10760#requestSample
Other Prominent Vendors
– Affitech A/S
– Allergan Inc.
– Chengdu Kanghong Biotech Co. Ltd.
– Gilead Sciences Inc.
– Lpath Inc.
– Mat Biopharma SAS
– Pfizer Inc.
– Promedior Inc.
– QLT Inc.
– Quark Pharmaceuticals Inc.
– Resolvyx Pharmaceuticals Inc.
– Sanwa Kagaku Kenkyusho Co. Ltd.
– Valeant Pharmaceuticals International Inc.
Key Market Drivers
– High Patient and Physician Satisfaction.
– For a full, detailed list, view this report.
Key Market Challenges
– High Cost of Treatment.
– For a full, detailed list, view this report.
Key Market Trends
– Strong Competition in the Market.
– For a full, detailed list, view this report.
The post Choroidal Neovascularization (CNV) Market 2015 will grow at a CAGR of 6.77% during 2013-2018 (http://www.medgadget.com/2015/05/choroidal-neovascularization-cnv-market-2015-will-grow-cagr-6-77-2013-2018.html) appeared first on Medgadget (http://www.medgadget.com).
http://feeds.feedburner.com/~ff/Medgadget?d=yIl2AUoC8zA (http://feeds.feedburner.com/~ff/Medgadget?a=iGgUCgHqySs:CmEEewBgLTc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/Medgadget?d=qj6IDK7rITs (http://feeds.feedburner.com/~ff/Medgadget?a=iGgUCgHqySs:CmEEewBgLTc:qj6IDK7rITs) http://feeds.feedburner.com/~ff/Medgadget?i=iGgUCgHqySs:CmEEewBgLTc:gIN9vFwOqvQ (http://feeds.feedburner.com/~ff/Medgadget?a=iGgUCgHqySs:CmEEewBgLTc:gIN9vFwOqvQ)
http://feeds.feedburner.com/~r/Medgadget/~4/iGgUCgHqySs
Choroidal Neovascularization (CNV) is defined as a process in which new blood vessels grow in the choroid through the bruch membrane, which is the innermost layer of the choroid, and attack the sub-retinal space. Even though most causes are idiopathic, the k**wn causes are related to degeneration, infections, choroidal tumors and/or trauma. As there is currently ** medical treatment for this disease, this ab**rmal growth can easily lead to impairment of sight or complete loss of vision.
Global CNV market will grow at a CAGR of 6.77 percent over the period 2013-2018. (http://www.marketresearchstore.com/report/global-choroidal-neovascularization-market-2014-2018-10760)
Covered in this Report
This report covers the present scenario and the growth prospects of the Global CNV market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of CNV
The report, the Global CNV Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global CNV market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
– Americas
– EMEA
– APAC
Key Vendors
– Bayer AG
– F. Hoffmann-La Roche Ltd.
– **vartis AG
– Regeneron Pharmaceuticals Inc.
Request For*Report Sample @ http://www.marketresearchstore.com/report/global-choroidal-neovascularization-market-2014-2018-10760#requestSample
Other Prominent Vendors
– Affitech A/S
– Allergan Inc.
– Chengdu Kanghong Biotech Co. Ltd.
– Gilead Sciences Inc.
– Lpath Inc.
– Mat Biopharma SAS
– Pfizer Inc.
– Promedior Inc.
– QLT Inc.
– Quark Pharmaceuticals Inc.
– Resolvyx Pharmaceuticals Inc.
– Sanwa Kagaku Kenkyusho Co. Ltd.
– Valeant Pharmaceuticals International Inc.
Key Market Drivers
– High Patient and Physician Satisfaction.
– For a full, detailed list, view this report.
Key Market Challenges
– High Cost of Treatment.
– For a full, detailed list, view this report.
Key Market Trends
– Strong Competition in the Market.
– For a full, detailed list, view this report.
The post Choroidal Neovascularization (CNV) Market 2015 will grow at a CAGR of 6.77% during 2013-2018 (http://www.medgadget.com/2015/05/choroidal-neovascularization-cnv-market-2015-will-grow-cagr-6-77-2013-2018.html) appeared first on Medgadget (http://www.medgadget.com).
http://feeds.feedburner.com/~ff/Medgadget?d=yIl2AUoC8zA (http://feeds.feedburner.com/~ff/Medgadget?a=iGgUCgHqySs:CmEEewBgLTc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/Medgadget?d=qj6IDK7rITs (http://feeds.feedburner.com/~ff/Medgadget?a=iGgUCgHqySs:CmEEewBgLTc:qj6IDK7rITs) http://feeds.feedburner.com/~ff/Medgadget?i=iGgUCgHqySs:CmEEewBgLTc:gIN9vFwOqvQ (http://feeds.feedburner.com/~ff/Medgadget?a=iGgUCgHqySs:CmEEewBgLTc:gIN9vFwOqvQ)
http://feeds.feedburner.com/~r/Medgadget/~4/iGgUCgHqySs